Saturday, 1 February 2020


Time

Topic

Speaker

Session I: Overview and Epidemiology of Adult and Pediatric Cancer Diseases: “Experiences Gained and Lessons Learned” Moderators: Dr. Reyad Mohsen, Dr. Abeer Alsayegh, Dr. Noora Alhammadi

08:00-09:00

Registration & Breakfast

 

09:00-09:15

Landscape of cancer genetic in Qatar current and future prospective

Dr. Salha Bujassoum Al Bader
Sr consultant medical oncologist / clinical leads of high risk - cancer genetic program / director of medical oncology fellowship training. Hamad Medical Corporation Qatar

09:15-09:30

Overview on pediatric rare cancers: experience from Qatar

Dr. Naima Almulla
Sr Consultant, Pediatric Hematology and Oncology, Sidra Medicine

09:30-09:45

Identification and characterization of rare pediatric brain tumor entities

Dr. David Jones
Group Leader - Pediatric Glioma Research, Hopp Children’s Cancer Center Heidelberg (KiTZ)

09:45-10:00

Rare cancer predisposition syndromes in children and adults

Dr. Nicola Dikow
Consultant, Institute of Human Genetics University of Heidelberg

10:00-11:00

Short coffee break followed by

Welcome and Opening Remarks from Dr. Saad Al Kaabi

Keynote Lecture: German Center for Rare Diseases
(Prof. Annette Grueters-Kieslich)

Dr. Saad Al Kaabi
Conference Chairperson

Prof. Annette Grueters-Kieslich

Session II

Prevention and Ethical Considerations in Genomic Medicine

Moderators: Dr. Tawfeg Ben Omran, Karen El-Akouri

11:00-11:15

Ethical and cultural considerations in genomic medicine

Dr. Al Hareth Al Khater
Deputy Medical Director, National Center for Cancer Care & Research, Chairman, Corporate Healthcare Ethics Committee, Hamad Medical Corporation

11:15-11:30

Islamic ethics in the genomic era

Dr. Mohamed Ghaly
Professor of Islam and Biomedical Ethics Research Center for Islamic Legislation & Ethics (CILE), College of Islamic Studies (CIS), Hamad Bin Khalifa University (HBKU)

11:30-11:45

Premarital genetic screening and counseling in Qatar

Dr. Mariam Al Mulla
Genetic Counselor, Department of Pediatrics, Hamad Medical Corporation

11:45-12:00

Prevention programs for hereditary cancer in Qatar

Dr. Reem Al Sulaiman
Interim Deputy Chair Medical Genetics Department, HMC
Assistant Chair of Rare Disease and Research Committee, HMC

12:00-13:30

Prayer & Lunch Break

 

Session III

Therapeutic Opportunities in the Era of Genomic Medicine: “Challenges and Success”

Moderators: Dr. Khaled Zamel, Dr. Javid Gaziev, Dr. Amna Gamil

13:30-13:45

An emerging treatment option for spinal muscular atrophy: “from lethality to cure”

Dr. Tawfeg Ben-Omran
MD Clinical and Metabolic Genetic Hamad Medical Corporation and Sidra Medicine Associate Professor, Weill Cornell Medical College

13:45-14:00

Gene therapy for hemoglobinopathies

Prof. Andreas Kulozik
Medical Director, Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg

14:00-14:15

Anemia of inflammation & iron in macrophages

Prof. Martina Muckenthaler
Department of Pediatric Oncology, Hematology, Immunology & Pulmonology, University of Heidelberg

14:15-14:30

Therapeutic advances in neurotransmitter disorders

Prof. Thomas Opladen
Deputy Head, Pediatric Neurology and Metabolic Medicine University of Heidelberg

14:30-14:45

Towards precision medicine in skin diseases

Prof. Martin Steinhoff
Chairman, Dept. of Dermatology & Venereology Director, HMC Translational Research Institute (iTRI) Director, HMC Institute for Dermatology Center of Excellence Chronic Skin Inflammation

Session IV

Living with Rare Diseases: Parents’ Experiences

Moderators: Dr. Tawfeg Ben Omran, Dr. Reem Alsulaiman

14:45-16:00

Parent 1 & 2

 
 

Closing of Day 1